STATCenter·
STAT+: FDA approves Roivant therapy for rare autoimmune disease
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.
Read at STAT →
Health · 1 sources covering this
STAT+: FDA approves Roivant therapy for rare autoimmune disease
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/59961fcb5bce1f1cd7087732df9f1ff4ebefc1ec" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: FDA approves Roivant therapy for rare autoimmune disease"></iframe>
